Pricing
Login
Login
Quiz MakerFlashcard MakerNote MakerStudy Guide MakerPodcast GeneratorAI Tutor
PDF to QuizPDF to NotesPDF to FlashcardsPDF to PodcastVideo to NotesView all use cases
Exam prep
NCLEX-RN QBank (Beta)
Subjects
MedicineNursingDentistryLawPharmacy
Pricing
Good Clinical Practice: ICH E6(R3) Foundations

Good Clinical Practice: ICH E6(R3) Foundations

Review modern Good Clinical Practice with independently authored questions on ICH E6(R3), participant protection, informed consent, IRB review, investigator and sponsor responsibilities, quality by design, and data governance. This independent educational resource is not an official ICH or FDA course and does not provide certification, legal advice, or study-specific operational direction.

Recommended next

30 questions ready

Start with a quiz

Answer from memory first, then use the existing quiz review flow for anything you miss.

Activities

Quiz30 Questions
Flashcards20 Cards
Study Notes5 Notes

Modules

Learn in sequence

Start with the earlier modules and work forward. Each one builds on the last, so the course gets more advanced as you go.
1

GCP Principles and Quality by Design

Understand what GCP protects and how E6(R3) uses critical thinking, proportionality, and quality by design.

GCP, Proportionality, and Quality by Design

2 min • Summary

GCP Principles and Quality by Design Practice

Quiz • 8 Questions

GCP Principles and Quality by Design Key Facts

Flashcards • 5 Cards

Official Sources, Attribution, and Scope

2 min • Summary

2

Participant Protection, IRB Review, and Consent

Review independent ethics oversight and the conditions for understandable, voluntary informed consent.

Independent Review and Informed Consent

2 min • Summary

Participant Protection, IRB Review, and Consent Practice

Quiz • 8 Questions

Participant Protection, IRB Review, and Consent Key Facts

Flashcards • 5 Cards

3

Investigator, Sponsor, and Oversight Responsibilities

Distinguish accountable roles, protocol adherence, qualified care, quality management, monitoring, and noncompliance response.

Accountability, Oversight, and Proportionate Monitoring

2 min • Summary

Investigator, Sponsor, and Oversight Responsibilities Practice

Quiz • 7 Questions

Investigator, Sponsor, and Oversight Responsibilities Key Facts

Flashcards • 5 Cards

4

Data Governance, Systems, Blinding, and Essential Records

Apply E6(R3) ideas to fit-for-purpose data capture, metadata, access, corrections, blinding, and record retention.

Data Integrity and Essential Records

3 min • Summary

Data Governance, Systems, Blinding, and Essential Records Practice

Quiz • 7 Questions

Data Governance, Systems, Blinding, and Essential Records Key Facts

Flashcards • 5 Cards

Materials

List of Questions30 questions
  1. Question 1
    • To protect participants and support reliable trial results
    • To make every clinical trial use the same operational procedures
    • To guarantee that every investigational product will be approved
    • To replace applicable national and local requirements
  2. Question 2
    • Apply the maximum possible control because all processes are equally critical
    • Choose controls proportionate to participant risk and the importance of the data or process
    • Omit documentation whenever a process seems routine
    • Use only controls copied from a previous trial
  3. Question 3
    • Adding more inspections after the trial is complete
    • Using only paper records to avoid technology risk
    • Designing quality into the trial by identifying important factors and risks early
    • Eliminating all protocol amendments
  4. Question 4
    • The frequency of optional internal status meetings
    • The order of routine copies in a noncritical archive
    • The visual theme of an internal training deck
    • Accurate assessment of a primary endpoint that drives the trial conclusion
  5. Question 5
    • It may be promotional and could distort an informed, voluntary decision
    • It uses too few technical terms
    • It does not describe the sponsor’s monitoring plan
    • It must include every protocol procedure
  6. Question 6
    • The sponsor no longer has any responsibility for that activity
    • Overall sponsor responsibility remains even when activities are transferred
    • The investigator automatically becomes responsible for the service provider
    • The service provider may change the protocol without authorization
  7. Question 7
    • To let them approve marketing claims
    • To remove the need for independent ethics review
    • To improve the relevance and feasibility of trial features that affect participants
    • To allow them to choose the statistical result
  8. Question 8
    • Collect every data point that could possibly be imagined
    • Avoid changing a process even when risk review shows it is ineffective
    • Use the same procedures regardless of trial risk or complexity
    • Collect data needed for the trial objectives using processes suited to their intended use
  9. Question 9
    • To safeguard participants’ rights, safety, and well-being through independent review
    • To market the trial to potential participants
    • To manage the sponsor’s project budget
    • To replace the investigator’s medical judgment
  10. Question 10
    • As soon as recruitment materials are drafted
    • Only after the required documented approval or favorable opinion is in place
    • After the first participant verbally agrees
    • Whenever the sponsor considers the trial low risk
  11. Question 11
    • To rewrite all study data
    • To perform the sponsor’s financial audit
    • To reassess participant protection as the trial continues and new information emerges
    • To select the investigators’ employees
  12. Question 12
    • Tell the person that withdrawal is not permitted
    • Ask for a signature before explaining risks
    • Use technical language so the document sounds authoritative
    • Provide enough time to decide, minimize coercion or undue influence, and use understandable language
  13. Question 13
    • By signing, you give up the right to seek compensation for negligent injury
    • You may ask questions before deciding
    • Participation is voluntary
    • The study involves research
  14. Question 14
    • The signed form should be destroyed after enrollment
    • A copy should be provided to the person who signed
    • Only the sponsor may keep a copy
    • The participant must waive access to trial information
  15. Question 15
    • A single “accept” button with no accessible study information
    • A system that prevents the participant from reviewing the form later
    • A process that supports comprehension, questions, appropriate signatures, and access to the information
    • A process that assumes everyone is comfortable with the same technology
  16. Question 16
    • Withhold it until the final report
    • Change the consent form without IRB/IEC involvement
    • Tell only participants who ask exactly the right question
    • Provide relevant new information in a timely way and follow required review and re-consent processes
  17. Question 17
    • Appropriate qualifications, adequate resources, and sufficient oversight of delegated activities
    • Relevant experience but insufficient staff and facilities
    • Adequate resources but no plan to oversee delegated work
    • Sponsor assurances without evidence of site feasibility
  18. Question 18
    • Delay action until the next scheduled meeting even if harm is imminent
    • Take the necessary protective action and promptly follow required documentation and reporting pathways
    • Permanently rewrite the protocol without review
    • Hide the deviation because it protected a participant
  19. Question 19
    • A sponsor medical writer designated to prepare safety summaries
    • The assigned monitor regardless of clinical qualifications
    • An appropriately qualified physician or, when appropriate, dentist or other qualified healthcare professional under local requirements
    • The IRB chair acting as the participant’s direct clinician
  20. Question 20
    • Guarantee that no error can ever occur
    • Focus only on document formatting
    • Transfer every activity to vendors and end oversight
    • Implement proportionate systems that protect participants and support reliable results
  21. Question 21
    • Clear allocation of activities, access to relevant information, and sponsor oversight proportionate to risk
    • No written allocation because the provider is experienced
    • The provider may redefine endpoints without agreement
    • The sponsor should avoid reviewing provider performance
  22. Question 22
    • Treat each as an isolated typo without assessment
    • Investigate significance and root causes, correct the issue, and prevent recurrence with proportionate escalation
    • Delete the affected records
    • Wait until publication before telling anyone
  23. Question 23
    • A requirement that every data field receive identical attention
    • The monitor’s preferred travel schedule
    • Risks to participants and to critical-to-quality factors, using suitable site and centralized methods
    • The number of pages in the protocol
  24. Question 24
    • It should collect as much information as possible, even if unrelated to objectives
    • It should allow undocumented changes by any user
    • It should prevent investigators from accessing their required data
    • It should be fit for purpose and capture protocol-required information reliably
  25. Question 25
    • They help reconstruct who performed important actions, when, and what changed
    • They make the interface look more modern
    • They eliminate the need for access controls
    • They allow original entries to be overwritten invisibly
  26. Question 26
    • A shared site account with detailed activity logging
    • Unique accounts with permissions appropriate to each user’s authorized role
    • Unique accounts that all receive full administrative permissions
    • Role-based accounts reviewed only after the trial is complete
  27. Question 27
    • To hide safety information from authorized decision-makers
    • To ensure every staff member knows assignments
    • To protect trial integrity while allowing justified access when needed
    • To make post hoc outcome changes easier
  28. Question 28
    • Every email written by anyone connected to the trial
    • Only documents stored on paper
    • Only the final publication
    • Records and relevant metadata that collectively allow evaluation and management of trial conduct and result reliability
  29. Question 29
    • Keep the correction attributable and traceable, including a reason when required
    • Replace the original without leaving evidence
    • Ask a colleague to use the same login
    • Delete the entire participant record
  30. Question 30
    • Vendor certification alone, without trial-specific assessment
    • A documented, risk-proportionate approach reflecting the system’s critical functions and potential impact
    • The same exhaustive validation effort for every system regardless of criticality
    • Validation after first use, provided any issues are logged
List of Flashcards20 flashcards
  1. Card 1GCP Principles and Quality by Design
  2. Card 2GCP Principles and Quality by Design
  3. Card 3GCP Principles and Quality by Design
  4. Card 4GCP Principles and Quality by Design
  5. Card 5GCP Principles and Quality by Design
  6. Card 6Participant Protection, IRB Review, and Consent
  7. Card 7Participant Protection, IRB Review, and Consent
  8. Card 8Participant Protection, IRB Review, and Consent
  9. Card 9Participant Protection, IRB Review, and Consent
  10. Card 10Participant Protection, IRB Review, and Consent
  11. Card 11Investigator, Sponsor, and Oversight Responsibilities
  12. Card 12Investigator, Sponsor, and Oversight Responsibilities
  13. Card 13Investigator, Sponsor, and Oversight Responsibilities
  14. Card 14Investigator, Sponsor, and Oversight Responsibilities
  15. Card 15Investigator, Sponsor, and Oversight Responsibilities
  16. Card 16Data Governance, Systems, Blinding, and Essential Records
  17. Card 17Data Governance, Systems, Blinding, and Essential Records
  18. Card 18Data Governance, Systems, Blinding, and Essential Records
  19. Card 19Data Governance, Systems, Blinding, and Essential Records
  20. Card 20Data Governance, Systems, Blinding, and Essential Records

Footer

DiscordTiktokInstagramXFacebookSupportChrome

Tools

  • AI Quiz Generator
  • AI Flashcard Generator
  • AI Note Maker
  • AI Podcast Generator
  • AI Study Guide Maker
  • AI Tutor

Subjects

  • Medicine
  • Nursing
  • Dentistry
  • Law
  • Pharmacy

Resources

  • Blog
  • API
  • Help Center
  • Browse courses
  • Free Courses

Legal

  • Terms
  • Privacy
  • DMCA
  • DPA
  • Cookies

Company

  • About Us
  • Security
  • Refunds
  • Disclaimer
  • Acceptable Usage
English